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Abstract
Background: Mutations in P0, the major protein of the myelin sheath in peripheral nerves, cause
the inherited peripheral neuropathies Charcot-Marie-Tooth disease type 1B (CMT1B), Dejerine-
Sottas syndrome (DSS) and congenital hypomyelination (CH). We reported earlier a de novo
insertional mutation c.662_663GC (Ala221fs) in a DSS patient. The c.662_663GC insertion results
in a frame shift mutation Ala221fs altering the C-terminal amino acid sequence. The adhesion-
relevant intracellular RSTK domain is replaced by a sequence similar to Na+/K+ ATPase. To further
clarify the molecular disease mechanisms in this sporadic patient we constructed wild type P0 and
the c.662_663GC mutant expression cassettes by site-specific mutagenesis and transfected the
constructs into insect cells (S2, High5). To trace the effects in live cells, green fluorescent protein
(GFP) has been added to the carboxyterminus of the wild type and mutated P0 protein.
Results: In contrast to the membrane-localized wild type P0-GFP the Ala221fs P0-GFP protein was
detectable almost only in the cytoplasm of the cells, and a complete loss of adhesion function was
observed.
Conclusions: The present study provides evidence that GFP is a versatile tool to trace in vivo
effects of P0 and its mutations. Not only a loss of adhesion function as a result of the loss of the
RSTK domain, but also altered intracellular trafficking indicated by a loss of membrane insertion
are possible consequences of the Ala221fs mutation.
Background
In the peripheral nervous system, peripheral myelin pro-
tein 22 (PMP22), myelin protein zero (P0) and connexin
32 (Cx32/GJB1) are well-characterised transmembrane
proteins expressed in Schwann cells. They function as ad-
hesive or gap-junction proteins. In humans, mutations in-
volving these 3 peripheral myelin genes and the gene
encoding a transcription factor, early growth response 2
(EGR2) [1–3], have been associated with Charcot-Marie-
Tooth disease (CMT) and several related inherited periph-
eral neuropathies. Several in vitro (cellular) and in vivo (ro-
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dent) models have been constructed to study the biology
of PMP22, P0, Cx32 and EGR2 [2–6].
Eighty-three distinct mutations in the P0 gene located on
chromosome 1q22-q23 are currently known [2,3]. P0 mu-
tations are usually associated with a typical CMT1 pheno-
type, characterised by severely reduced NCVs and signs of
de- and remyelination on sural nerve biopsy [6,7]. How-
ever, some P0 mutations lead to a more severe Dejerine
Sottas Syndrome (DSS) phenotype or even congenital hy-
pomyelination (CH) [8]. Identical P0  mutations have
been reported in association with either a CMT1 or a DSS
phenotype [3,7,9]. Recently, P0 mutations have also been
found in CMT2 patients, e. g. the Thr124Met mutation
which was associated with highly variable NCVs, deaf-
ness, pupilary abnormalities and clusters of de- and remy-
elinating axons on peripheral nerve biopsy [10,11]. One
inherited frameshift mutation (c.306delA, Val102fs),
probably leading to a loss-of-function allele, has been de-
scribed [8]. In this case, the parents were heterozygous for
the Val102fs mutation and had a mild neuropathy, but
their two children were homozygous for the same muta-
tion and suffered from DSS.
P0 encodes the most abundant protein of peripheral nerv-
ous system myelin, is localized in the compact myelin and
contributes to the formation of the intraperiod and major
dense lines [25,26]. The structure of the extracellular do-
main of P0 resembles an immunoglobulin variable do-
main [12,27–29]. This domain is important for the
homotypic interactions that convey the self-adhesive
properties that are essential to maintain myelin compac-
tion and integrity [13,25,26]. During Schwann cell devel-
opment, P0 is induced with genes encoding other myelin
proteins such as PMP22, followed by myelin basic protein
(MBP) and myelin associated glycoprotein (MAG) [14].
The capacity of mutated P0 proteins to integrate into cel-
lular membranes and to exert their function as an adhe-
sion molecule has been studied in cellular models. These
in vitro studies have been performed in CHO cells
[13,15,28,29], in S2 insect cells [16] which do usually not
adhere in the wildtype condition, rat pheochromocytoma
PC12 cells [17], L cells and HeLa cells [18]. In suspension,
transfected cells expressing normal P0 adhere to each oth-
er by homophilic interaction of the extracellular domains
of P0 and also by association with apposing plasma mem-
branes [13]. We reported earlier a de novo insertional mu-
tation (c.662_663GC, Ala221fs) for an affected male child
in a family of German descent [19]. To clarify the patho-
mechanism of the DSS patient with Ala221fs we studied
the effects on the adhesion capability and intracellular
trafficking of this mutation compared to the wildtype.
Green fluorescent protein (GFP) is a helpful tool to ob-
serve cellular events in vivo.
We report here both, altered intracellular trafficking and
reduced adhesion of the mutant P0 in insect cells.
Results
We based the adhesion experiments on insect cells be-
cause, under well-defined cell culture conditions, the nat-
ural self adhesiveness of these cells can be minimized. The
cell-cell adhesion of S2 cells before and after transfection
or induction of the respective gene expression can be
traced at the light microscope level (fig. 1). The relative
cell-cell adhesion was compared with non-transfected
Figure 1
Light microscopy of S2 cells. In (A) the P0 transfected S2 cells are not induced to express protein and show only limited
aggregation tendencies. In (B) the transfectants were induced with copperions and cell aggregates are clearly visible already 1-2
hours after induction. Pictures were taken at 10 x magnification.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/29
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cells. For tracing of the intracellular trafficking in live cells,
green fluorescent protein (GFP) was included in frame to
the C-terminus of wild type and Ala221fs P0 in the respec-
tive expression vectors, pEXII and pEXIV. After transfec-
tion, selection and induction of expression the P0-GFP
signals of the Ala221fs mutation were predominantly lo-
calized in cytosolic vesicles and a membrane insertion was
not visible by fluorescence microscopy  (fig. 2). For the
wild type P0-GFP fusion protein, cell surface insertion and
strong cell-cell adhesion were observed  (fig. 3). As a con-
trol, we cloned GFP alone into the pEXII vector and trans-
fected this construct into the S2 cells. A GFP signal was not
observed at the cell surface but in the cytosol and also in
the nucleus (fig. 4). Fig. 5 shows three different micro-
scopic levels of P0-GFP expressing S2 cells. All cellular lay-
ers, above, on and below the equivalent of a cell equator,
show intracellular vesicles associated with P0-GFP fusion
protein. As shown in Fig. 5B the cell surface insertion of
the wild type variant is clearly visible, the Ala221fs muta-
tion in fusion with GFP revealed only the P0-GFP associ-
ated vesicles (fig. 2).
Semiquantitative RT-PCR performed on S2 and High5
cells transfected with wild type and mutated P0-GFP con-
structs suggested that similar levels of RNA were present,
when GAPDH was taken as an internal standard (Fig. 6).
To analyze overall GFP fusion protein expression Western
blots were performed to identify the respective proteins
immunologically. We constructed P0-GFP fusions as well
as P0-V5 epitope fusions (vector pIB/V5-His) to obtain
Figure 2
Fluorescence microscopy of a S2 cell transfected
with the Ala221fs mutation in fusion with GFP (vec-
tor pEXII). None of the different layers analysed by fluores-
cence microscopy showed a membrane insertion of P0-GFP.
Fluorescent cytoplasmic vesicles (arrows) are clearly visible.
The nucleus is free of fluorescence  (see fig. 4).
Figure 3
Aggregated insect cells after transfection with wild
type P0/GFP fusion in vector pEXII. The fluorescent cell
surface indicates the membrane incorporation of the wild
type P0-GFP fusion protein which initiates the enhanced cell-
cell agglutination.
Figure 4
S2 cells transfected with GFP inserted in the pEXII
expression vector. The overall staining of the cells
expressing GFP only is clearly visible. Also the nucleus shows
green fluorescence in contrast to the cells expressing wild
type P0-GFP fusion protein (see fig. 2,5).BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/29
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highly specific antibody detection of the P0 and P0-GFP
expression in immunoblots. When the V5- epitope anti-
body was used clear single bands at the expected molecu-
lar weights of the respective proteins were seen in similar
amounts (fig. 7).
Finally, we performed an adhesion test with two types of
insect cells (S2 and High5) for the Ala221fs mutation, P0
wild type in fusion with GFP, GFP alone, cells transfected
with an empty vector and non-transfected cells. Both types
of insect cells gave comparable results with all types of
transfected DNAs. A loss of adhesion of the Ala221fs mu-
tation compared to the P0 wild type is obvious (fig. 5, 8,
9). The remaining adhesion is as low as for untransfected
and GFP alone transfected cells. The fusion of GFP with
wild type P0 in both cell types has only slight or no influ-
ence on its adhesion function. Hence, it is now possible to
visualize the P0 trafficking as well as the cellular effects of
mutations in live cells.
Discussion
Here we present data on a P0 mutation with regard to its
adhesion function. For our analysis, the P0 and GFP genes
were fused at the carboxyterminus of P0. This fusion al-
lows the observation of the intracellular trafficking of
both, wild type and mutated P0 protein in live cells. As a
first mutation we tested the Ala221fs variation which pro-
duces a completely altered carboxyterminal amino acid
sequence with homologies to Na+/K+ ATPase [19]. Re-
cently, a systematic analysis of carboxyterminal P0 muta-
tions was reported, showing that the RSTK motif is
essential for adhesion [18]. This motif is the target of PKC-
mediated phosphorylation, and the lack of this phospho-
rylation motif hampers the adhesion function of P0. The
Ala221fs mutation eliminates the RSTK motif, resulting in
a complete loss of adhesion. Interestingly, a P0 protein
truncated by 28 amino acids at the carboxyterminal end
loses his adhesion function, although it is found at the cell
surface [18]. The Ala221fs mutation, however, results in a
loss of cell surface insertion detectable under fluorescent
microscopy conditions using the GFP fusion. A loss of ad-
hesion function is therefore the consequence of impaired
ability to reach the cell surface. It is conceivable that al-
tered intracellular trafficking is responsible for additional
mutational mechanisms. Earlier reports suggested a dom-
inant-negative effect of truncated P0 proteins on the func-
tion of the wild type P0 [21], as seen in co-expression
experiments with wild type P0 and P0 proteins truncated
by 52 and 59 amino acids also eliminating the function-
ally important RSTK motif. These truncated proteins
reached the cell surface in amounts comparable to the
wild type, most likely resulting in disturbed protein-pro-
tein interaction and reducing adhesion was by 80%. In
our experiments adhesion of Ala221fs transfected cells
was reduced by almost 100 %. However, the overall effects
of a co-expression of wild type and Ala221fs P0 mutation
remain to be established. Preliminary co-expression ex-
periments using wild type P0 and the Ala221fs mutation
indicate that adhesion of the transfected cells is dramati-
cally reduced (data not shown). Experiments are under-
way to perform a more detailed analysis of the relative
expression levels and of the intracellular interactions of
the transfected proteins.
Conclusions
GFP in fusion with P0 has proven to be a versatile tool to
visualize effects of pathogenic mutations in live cells. GFP
expressed in frame does not hamper the adhesion func-
tion of the wild type P0. A combination of colors from dif-
ferent fluorescent proteins for wild type and mutated P0
Figure 5
Fluorescence microscopy of S2 cells expressing wild type P0/GFP in three different layers. In all layers, green ves-
icles are clearly visible in the cytoplasm. In (B) and (C) the equator of the cells is matched and the green fluorescence of the
membrane is visible indicating the functional incorporation of wild type P0-GFP fusion proteins. Arrows indicate wild type P0-
GFP in cytosolic vesicles and at the cell surface. The nuclei are free of fluorescence in contrast to the isolated GFP fluores-
cence (see fig. 4).BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/29
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will help to clarify the disturbed protein-protein interac-
tions in vivo. This system provides the basis for deeper in-
sights into the mutational effects via co-expression
experiments of wild type P0 and mutations.
Methods
Patient report
The affected child showed signs of sensory loss and a
markedly reduced nerve conduction velocity (NCV, 15 m/
s) at age four years. The non consanguineous parents re-
vealed no clinical symptoms of peripheral neuropathy
and electrophysiological examination showed NCVs
within the normal range. A sural nerve biopsy was not
done [19]. SSCP analysis revealed an aberrant pattern of
bands for the affected child, not for the parents and not in
a prenatal diagnosis performed on DNA derived from am-
niotic fluid, in exon 6 of P0. Direct sequencing revealed a
GC insertion (c.662_663GC) initially identified as
INS707GC mutation according to the P0 cDNA number-
ing of [22]. The GC insertion alters the carboxyterminal
amino acid sequence of the human P0 cDNA beginning at
Alanin in position 221 creating homology to a conserved
domain of Na+/K+ ATPase and loss of the PKC substrate
motif (RSTK).
Figure 6
Semiquantitative determination of RNA in non transfected and transfected S2 and High5 insect cells by RT-
PCR. The respective RT-PCR products derived from the different transfectants revealed the expected sizes as indicated by
the positive controls: wild type P0, GFP, P0-GFP and GAPDH. The GAPDH products indicate  similar RNA amounts for each
experimental value.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/29
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Preparation of wild type and mutant P0
The human wild type P0 cDNA was kindly provided by
Prof. Hayasaka to perform the here presented experi-
ments. Initially, a combination of vectors contributing al-
pha-amanitin resistance (pPC4) and heavy-metal
inducible insect-specific promotor (pRmha3) had been
used. To obtain stably expressing cell lines a vector com-
prising the expression cassette, a copia element for chro-
mosomal integration, a neomycin resistance and the
metallothionein inducible promotor was constructed and
named pEXII. The High5 system (Invitrogen, Paisley, UK)
was tested for transient P0 expression, too. The pIB/V5-
His vector was modified in its polylinker and renamed to
pEXIV.
A quick and reliable method to introduce mutations by
PCR was used as reported [23]. To determine the transfec-
tion efficiency fluorescence in situ hybridisation (FISH)
was used resulting in more than 90% of all cells with spe-
cific pPC4 and pRmha3-P0 fluorescence signals and indi-
cating that highly effective transfection was possible [24].
Cell culture and transfection
Transfection was performed using InsectinPlus (Invitro-
gen). One day before transfection the cells were trans-
ferred to 6-well plates and grown overnight at 25°C in the
incubator. For both, S2 and HighV transfection, we used 3
µg plasmid DNA, 10 µl InsectinPlus and 500 µl of Insect
cell medium. A 15 sec. mixing was followed by a 20 min
incubation at 21°C. During this time the medium was re-
moved from the 6-well plates with the cells located on the
bottom of the wells. The transfection suspension was pi-
petted carefully onto the cells. After a 4 h incubation at
25°C, 1 ml medium was added. After 48 hours the medi-
um was removed and 2 ml fresh medium was added. After
two further days, the cells were transferred to  cell culture
bottles (25 ml) and supplied with antibiotics (2 mg/ml
neomycin for pEXII/S2 cells; 8 mg/ml blasticidin for pEX-
IV/HighV).
The cells were grown in suspensions, at 25°C and 100%
humidity in an incubator. Drosophila-SFM or HighV-me-
dium was used according to the manufacturers guidelines.
S2-cells were fed at least once a week, the HighV-cells eve-
ry 3–4 days. The cells in suspension were counted in Neu-
bauer- or Fuchs-Rosenthal-chambers. Cells were collected
by centrifugation at 400-600 x g for 10 min and washed
once in 1 x PBS.
Immunoblot analysis
After SDS-polyacrylamid gelelectrophoresis (15% gel) the
proteins were transferred to a nitrocellulose membrane
(Schleicher & Schüll, Keene, USA) using a Minitrans-Blot
Eletrophoretic Transfer chamber (Biometra, Göttingen,
Germany). The gel was equilibrated in transfer buffer
(24.8 mM Tris-base, 192 mM glycin, 20% methanol, pH
8.3) for 20 min. The transfer membrane was first rinsed
with water and then equilibrated with transfer buffer. The
further transfer, blocking and washing steps were per-
formed according to the manufacturer's (Biometra) in-
structions.
RT-PCR
To isolate RNA from the insect cells the mini-protocol of
the RNEASY system (Quiagen, Hilden, Germany) was
used. 5 × 106 to 1 × 107 cells were harvested at 400-600 x
g for 10 min. The cDNA synthesis was performed using 5
µg RNA and the random hexanucleotide system from Boe-
hringer Ingelheim. The subsequent PCR reactions were
performed according to standard protocols. For detection
of GAPDH the primers GAPDH-start 5'-GAC GCC TAC
AGC CCC GAC – 3' and GAPDH-stop 5'-AAG ATC CAC
AAC GGA GAC – 3' were used. For detection of PO the
primers P0-ATG-NotI 5'-GCG AAT TCG CGC GGC CGC
GCA TGG CTC CTG GGG CTC CCT CAT CCA – 3' and P0-
TAG-NheI 5'-CGG CTA GCC TAT TTC TTA TCC TTG GGA
GAC TCC C – 3' were used. For the detection of P0-GFP,
Figure 7
Western blot analysis of P0 protein levels with anti-
bodies directed against the V5-epitope. The V5 epitope
fused in-frame with P0 reveals expected molecular weights
for GFP and GFP fused with P0 proteins.  Lane 1: purified
recombinant GFP. Lane 2: crude protein extract of sciatic
nerve. Lane 3: protein extract of GFP-V5 transfected insect
cells. Lane 4: protein extract of wild type P0-GFP-V5 trans-
fected cells. Lane 5: moelcular weight standard.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/29
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fusion RNA the GFP-stop/NheI 5'-GCG CTA GCT TAT
TTG TAT AGT TCA TCC ATG – 3' primer was used at the
3' end.
GFP detection assay
An aliquot (1 ml) of the insect cell suspension was centri-
fuged at 400-600 x g for 2 min and resuspended in PBS.
Drops of the cell suspension were transferred to micro-
scopic slides.  The evaluation of the green fluorescence of
the cell suspensions was performed on a Zeiss Axioplan
Microscope with ISIS imaging software and GFP fluores-
cent filter.
Adhesion assay
To avoid measurement of adhesion of dead cells, a trypan
blue staining [30] was performed and only cells which
had not incorporated trypan blue were included to calcu-
late the particle number ratios. An aliquot of 200 µl cell
supsension was mixed with 200 µl trypan blue solution
and left for 5 min at 21ºC. After 2 min centrifugation at
400-600 x g the supernatant was discarded and the pellet
resuspended in PBS. This supspension was then examined
on  a microscopic slide.  P0 expression in S2 cells was in-
duced by copper ions overnight [31]. An aliquot (1ml) of
the insect cell suspension was centrifuged at 400-600 x g
for 2 min and resuspended in PBS. Drops of these cells
were transferred to microscopic slides and the Fuchs-
Rosenthal chamber for calculation of the particle number
per volume. The adhesion test was performed in a Fuchs-
Rosenthal-chamber.
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